Furthermore, the global oncology/cancer drugs market growth is propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace.
Tag Archives: Oncology Drugs Market
Oncology/Cancer Drugs Market Expected to reach $274.40 Billion by 2030 | By Allied Market Research
North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, ease of drug availability.
Canada Oncology Drugs Market Current Scenario 2022-2030 | AstraZeneca, Gilead, Roche
Allied Market Research added new research on Canada Oncology Drugs Market- Opportunity Analysis and Industry Forecast, 2022–2030. The Oncology Drugs market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and …
In the Crowded Oncology/Cancer Drugs Market, There’s Room for Revenue Growth
Increase in incidence of cancer, rise in the global geriatric population, and surge in government expenditure on healthcare have boosted the global oncology/cancer drugs market. However, adverse effect associated with use of cancer drugs hinders the market growth. On the contrary, rise in number of pipeline drugs and high growth potential in untapped emerging economies …
Continue reading “In the Crowded Oncology/Cancer Drugs Market, There’s Room for Revenue Growth”